Evaluation of Rint1 as a modifier of intestinal tumorigenesis and cancer risk

Karla L Otterpohl1, Karen A Gould1

  • 1Department of Genetics, Cell Biology and Anatomy, University of Nebraska Medical Center, Omaha, Nebraska, United States of America.

Plos One
|March 7, 2017
PubMed

Insights

Rad50 Interacting Protein 1 (Rint1) plays a role in cellular homeostasis. Studies show Rint1 variants are linked to cancer risk, but its role in tumorigenesis remains unclear.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Rad50 Interacting Protein 1 (Rint1) is crucial for cellular homeostasis, affecting organelle integrity and cell cycle regulation.
  • Rint1's role in cancer is debated, potentially acting as a tumor suppressor or oncogene depending on context.
  • Germline RINT1 variants are associated with increased breast and Lynch syndrome cancer risks, but their functional impact is unknown.

Purpose of the Study:

  • To investigate the impact of Rint1 on intestinal tumorigenesis in ApcMin/+ mice.
  • To determine if Rint1 acts as a tumor suppressor in the context of intestinal cancer.
  • To analyze the association of RINT1 alterations with colorectal cancer development.

Main Methods:

  • Generated Rint1+/-; ApcMin/+ mice to assess tumorigenesis.
  • Analyzed somatic Rint1 allele loss in intestinal tumors.
  • Examined RINT1 expression and mutation data in human colorectal cancer databases (COSMIC, ONCOMINE).
  • Performed in vitro studies on RINT1 missense variants.

Main Results:

  • Heterozygosity for Rint1 knockout did not affect intestinal tumorigenesis in ApcMin/+ mice.
  • No somatic loss of the remaining Rint1 allele was observed in tumors.
  • Rint1+/- mice on a pure C57BL/6J background showed no spontaneous tumor development.
  • RINT1 overexpression and somatic missense mutations correlated with colorectal cancer development.
  • In vitro analysis indicated potential functional impact of RINT1 missense variants.

Conclusions:

  • Rint1 does not appear to function as a tumor suppressor in the context of ApcMin/+ driven intestinal tumorigenesis.
  • RINT1 alterations, including overexpression and somatic mutations, are associated with colorectal cancer.
  • Further research is needed to elucidate the precise role of Rint1 variants in cancer etiology.

Related Concept Videos

Non-LTR Retrotransposons03:18

Non-LTR Retrotransposons

As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
13.6K
Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
2.1K
Role Of Notch Signalling In Intestinal Stem Cell Renewal01:12

Role Of Notch Signalling In Intestinal Stem Cell Renewal

Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
2.6K
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
4.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
10.0K
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
7.4K